SOLACI-SOCIME 2022 | Mitral valve replacement

Read the most outstanding articles from the first day of the SOLACI-SOCIME 2022 Congress.

In this case, consult the presentation by Dr. Ignacio Amat Santos, entitled “Mitral valve replacement”

amat-santos-tmvr


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI-SOCIME 2022 | Big Necks, (PEVAR IN HOSTILE NECK) – Dr. Juan Varela

Veja esta apresentação do Dr. Juan Varela (COL) durante o Congresso SOLACI-SOCIME 2022 realizado na Expo Santa Fé, CDMX nos dias 4, 5 e...

SOLACI-SOCIME 2022 | Advances in the design of STENTS in PCI: DIABETES MELLITUS – Dr. Roxana Mehran

Enjoy this master conference given by Dr. Roxana Mehran during the SOLACI-SOCIME 2022 Congress held at Expo Santa Fé, CDMX on August 4, 5...

SOLACI-SOCIME 2022 | Management of entrapped equipment, by Dr. José Velazco

Read the most outstanding articles from the first day of the SOLACI-SOCIME 2022 Congress. In this case, consult the presentation by Dr. José Velazco, entitled...

SOLACI-SOCIME 2022 | Transcatheter treatment of mitral valve regurgitation, by Dr. Luis Nombela Franco

Read the most outstanding articles from the first day of the SOLACI-SOCIME 2022 Congress. In this case, consult the presentation by Dr. Luis Nombela Franco,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....